• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies.

作者信息

Niu Alex, Ning Bo, Socola Francisco, Safah Hana, Reynolds Tim, Ibrahim Moayed, Safa Firas, Alfonso Tina, Luk Alfred, Mushatt David M, Hu Tony, Saba Nakhle S

机构信息

Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, LA, USA.

Department of Biochemistry & Molecular Biology, Tulane University, New Orleans, LA, USA.

出版信息

Leuk Res. 2021 Jul;106:106582. doi: 10.1016/j.leukres.2021.106582. Epub 2021 Apr 24.

DOI:10.1016/j.leukres.2021.106582
PMID:33933714
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8064808/
Abstract
摘要

相似文献

1
High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies.高死亡率与高假阴性率：血液系统恶性肿瘤患者的新型冠状病毒肺炎感染情况
Leuk Res. 2021 Jul;106:106582. doi: 10.1016/j.leukres.2021.106582. Epub 2021 Apr 24.
2
COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic.COVID-19 感染 96 例血液系统疾病患者：来自捷克共和国的首个单中心经验。
Clin Lymphoma Myeloma Leuk. 2021 Sep;21(9):606-612. doi: 10.1016/j.clml.2021.04.016. Epub 2021 May 31.
3
Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?在新冠疫情时代，是否需要重新考虑在异基因造血细胞移植后使用 G-CSF？
Br J Cancer. 2021 Mar;124(7):1183. doi: 10.1038/s41416-020-01195-8. Epub 2021 Jan 4.
4
Reinfection versus failure of viral clearance in a COVID-19 patient with hematologic malignancy.一名血液系统恶性肿瘤的COVID-19患者的再次感染与病毒清除失败
Leuk Res. 2021 Feb;101:106514. doi: 10.1016/j.leukres.2021.106514. Epub 2021 Jan 20.
5
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).COVID-19 感染成年血液病患者：欧洲血液学协会调查（EPICOVIDEHA）。
J Hematol Oncol. 2021 Oct 14;14(1):168. doi: 10.1186/s13045-021-01177-0.
6
Perspective: SARS-CoV-2, COVID-19 and Haematologists.观点：严重急性呼吸综合征冠状病毒2、冠状病毒病2019与血液科医生。
Acta Haematol. 2021;144(2):117-121. doi: 10.1159/000508021. Epub 2020 May 6.
7
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside.血液恶性肿瘤患者的长程和持续性 COVID-19：从基础到临床。
Curr Opin Infect Dis. 2022 Aug 1;35(4):271-279. doi: 10.1097/QCO.0000000000000841. Epub 2022 Jul 5.
8
COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies.COVID-19 与季节性流感：血液系统恶性肿瘤患者的对比分析。
Leuk Lymphoma. 2022 Mar;63(3):664-671. doi: 10.1080/10428194.2021.1992626. Epub 2021 Oct 20.
9
Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom.英国一家大型城市医疗信托机构中血液系统恶性肿瘤合并新型冠状病毒肺炎感染住院患者的结局
Leuk Lymphoma. 2021 Feb;62(2):469-472. doi: 10.1080/10428194.2020.1838506. Epub 2020 Nov 9.
10
ASH Registry Offers Insights on COVID-19 in Patients with Hematologic Malignancies.ASH 注册研究提供血液系统恶性肿瘤患者 COVID-19 相关信息。
Oncologist. 2021 Feb;26 Suppl 1(Suppl 1):S17-S18. doi: 10.1002/onco.13657. Epub 2020 Dec 28.

引用本文的文献

1
Infections Simulating Immune Checkpoint Inhibitor Toxicities: Uncommon and Deceptive.模拟免疫检查点抑制剂毒性的感染：罕见且具有欺骗性。
Open Forum Infect Dis. 2022 Oct 27;9(11):ofac570. doi: 10.1093/ofid/ofac570. eCollection 2022 Nov.
2
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis.预测 SARS-CoV-2 感染在血液病患者中的临床演变的因素：系统评价和荟萃分析。
Hematol Oncol. 2023 Feb;41(1):16-25. doi: 10.1002/hon.3084. Epub 2022 Oct 20.
3
Reinfection versus failure of viral clearance in a COVID-19 patient with hematologic malignancy.

本文引用的文献

1
Safety and efficacy of COVID-19 convalescent plasma in severe pulmonary disease: A report of 17 patients.新冠康复者血浆治疗重症肺部疾病的安全性和有效性：17例患者的报告
Transfus Med. 2021 Jun;31(3):217-220. doi: 10.1111/tme.12729. Epub 2020 Oct 19.
2
Comorbidity and its Impact on Patients with COVID-19.合并症及其对COVID-19患者的影响。
SN Compr Clin Med. 2020;2(8):1069-1076. doi: 10.1007/s42399-020-00363-4. Epub 2020 Jun 25.
3
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
一名血液系统恶性肿瘤的COVID-19患者的再次感染与病毒清除失败
Leuk Res. 2021 Feb;101:106514. doi: 10.1016/j.leukres.2021.106514. Epub 2021 Jan 20.
意大利血液系统恶性肿瘤患者中与COVID-19严重程度相关的临床特征和危险因素：一项回顾性、多中心队列研究。
Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
4
Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis.超高灵敏且高通量的 CRISPR 助力 COVID-19 诊断。
Biosens Bioelectron. 2020 Sep 15;164:112316. doi: 10.1016/j.bios.2020.112316. Epub 2020 May 23.
5
COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma.异基因干细胞移植中的新冠病毒肺炎：高假阴性概率以及CRISPR和恢复期血浆的作用
Bone Marrow Transplant. 2020 Dec;55(12):2354-2356. doi: 10.1038/s41409-020-0972-8. Epub 2020 Jun 15.
6
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.新冠肺炎患者恢复期血浆疗法对病毒脱落和生存的影响。
J Infect Dis. 2020 Jun 16;222(1):38-43. doi: 10.1093/infdis/jiaa228.
7
The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control.《2019年冠状病毒病大流行：分类学、遗传学、流行病学、诊断、治疗及防控的全面综述》
J Clin Med. 2020 Apr 24;9(4):1225. doi: 10.3390/jcm9041225.
8
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.2020 年 1 月至 3 月在中国浙江省感染 SARS-CoV-2 的患者的病毒载量动态和疾病严重程度：回顾性队列研究。
BMJ. 2020 Apr 21;369:m1443. doi: 10.1136/bmj.m1443.
9
Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.新冠肺炎患者中受抑制的 T 细胞介导的免疫：来自中国武汉的临床回顾性研究。
J Infect. 2020 Jul;81(1):e51-e60. doi: 10.1016/j.jinf.2020.04.012. Epub 2020 Apr 18.
10
Compassionate Use of Remdesivir for Patients with Severe Covid-19.瑞德西韦在治疗重症 COVID-19 患者中的同情使用。
N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.